AB
Arbutus Biopharma Corp
🇺🇸XNAS.ABUSUnited StatesHealthcare
$5.04USDdown -0.02 (-0.4%)ClosedDelayed12:14 AM
Price$5.04-0.02 (-0.4%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- CA03879J1003
- CUSIP
- 87911B209
Company
- Employees
- 19
- Headquarters
- Warminster, United States
- Website
- https://www.arbutusbio.com
- CEO
- Ms. Lindsay Androski J.D., M.B.A.
Market
- Shares outstanding
- 198.1M
- Market cap
- $998.45M
Highlights
- Market cap
- $998.45M
- EPS LTM
- $0.77calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- 6.52calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $181.72M+1,078.78%up year on year
- Net income
- $153.05M+382.12%up year on year
- Gross margin
- 99.98%+752%up year on year
- Free cash flow
- -$24.63M+59.15%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.